Evidence map›Paper›PMID 22168421›Full record

ReviewImmunological reviews2012

Immune modulation during latent herpesvirus infection.

Douglas W White, R Suzanne Beard, Erik S Barton

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 154 citations in OpenAlex.

  1. Trial
  2. Herpetic reactivation during radiotherapy treatment for gynaecological cancers-a retrospective observational study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  3. Article
  4. Article
  5. Review
  6. Host-Microbiome Interactions in Chronic Itch.Journal of clinical medicine · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Immune Modulatory Effects of Vitamin D on Herpesvirus Infections.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Glutaminolysis of CD4Journal of inflammation research · 2024
    Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Douglas W WhiteDivision of Rheumatology, Gundersen Lutheran Medical Center, La Crosse, WI, USA.
R Suzanne Beard
Erik S Barton
Purdue University West Lafayette · USWake Forest University · US

Funding

Interferon Alpha Regulation of Murine Gammaherpesvirus LatencyR01AI080775 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GRAYSON, JASON MITCHELL · 2010 to 2014
$1.8M
Molecular mechanisms of gammaherpesvirus latency and reactivationK08AI079011 · NIAID · WASHINGTON UNIVERSITY · PI WHITE, DOUGLAS W. · 2008 to 2009
$113k
NIAID NIH HHS K08 AI079011NIAID NIH HHS K08AI079011NIAID NIH HHS R01 AI080775NIAID NIH HHS R01AI080775
6 · The paper itself

Abstract

Nearly all human beings, by the time they reach adolescence, are infected with multiple herpesviruses. At any given time, this family of viruses accounts for 35-40 billion human infections worldwide, making herpesviruses among the most prevalent pathogens known to exist. Compared to most other viruses, herpesviruses are also unique in that infection lasts the life of the host. Remarkably, despite their prevalence and persistence, little is known about how these viruses interact with their hosts, especially during the clinically asymptomatic phase of infection referred to as latency. This review explores data in human and animal systems that reveal the ability of latent herpesviruses to modulate the immune response to self and environmental antigens. From the perspective of the host, there are both potentially detrimental and surprisingly beneficial effects of this lifelong interaction. The realization that latent herpesvirus infection modulates immune responses in asymptomatic hosts forces us to reconsider what constitutes a 'normal' immune system in a healthy individual.

Indexed as

ImmunomodulationAnimalsDisease Models, AnimalHerpesviridaeHerpesviridae InfectionsHost-Pathogen InteractionsHumansVirus Latency

Identifiers

PMID22168421
PMCPMC3243940
OpenAlexW1928377279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.